Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...

Treatment represents a new approach that could potentially restore brain cells lost due to Parkinson’s disease ...

Protease hypersensitivity leaves lasting immune memory in lung tissue, influencing future inflammation. Read more.

CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.

Bristol Myers Squibb BMY has delivered a strong performance year to date with its shares gaining 10.2% compared with the ...

Right ventricular (RV) remodeling and dysfunction are serious cardiovascular consequences due to prolonged hypoxic exposure, ...

Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat.Even with effective antiretroviral therapy, immune ...

Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease ...

Sulforaphane also reverses aberrant DNA methylation patterns, effectively resetting the cancer cell’s epigenome toward normal ...